Endothelin type A receptor (ET A R) plays an important role in some cardiovascular disorders where ET A R levels are increased. However, regulatory mechanisms for ET A R levels are unknown. Here, we identified Jun activation domain-binding protein 1 (Jab1) as an ET A R-interacting protein by yeast two-hybrid screening of human heart cDNA library using carboxyl terminal tail (C-tail) of ET A R as a bait.
Introduction
G protein-coupled receptors (GPCRs) interact with intracellular proteins such as heterotrimeric G proteins, GPCR kinases, second messenger-dependent protein kinases and -arrestin [1, 2] . While the functional consequences of these interactions are well characterized, recent studies have raised the possibility that some of the physiological actions of GPCRs are not mediated by the interaction of GPCRs with the proteins listed above [2] . Moreover, recent studies using yeast two-hybrid system and GST pull-down assay have identified a growing number of additional intracellular proteins that directly bind to GPCRs, especially C-tail of GPCRs [3] . While the functional consequences of these interactions have not always been clarified, it seems that the formation of such GPCR and GPCR-interacting protein (GIP) complexes result in the regulation of the activity of GIP, the activity of the associated GPCRs, and intracellular trafficking of GPCRs [4] . Until now, more than 50 GIPs interacting with C-tails of a variety of GPCRs have been identified [3] . In some cases, it has been found that more than 5 GIPs interact with a single GPCR.
Endothelin-1 (ET-1) is a vasoconstricting peptide of 21 amino acids which is synthesized and released in endothelial cells of vessels [5] . ET-1 also possesses the activity to stimulate cell growth [6, 7] .
Therefore, ET-1 is considered to play important roles in the physiological control of blood pressure and cardiac function and also in genesis and development of cardiovascular diseases such as atherosclerosis [8] , cardiac remodeling accompanying chronic heart failure [7] , pulmonary hypertension [9] . There are two types of receptors for ET-1, endothelin type A receptor (ET A R) and ET B R, both of which are GPCRs [10, 11] . ET A R is coupled with G q and G s [12, 13] , while ET B R is coupled with G q and G i [12, 14] .
Notably, levels of ET receptors as well as ET-1 are reported to be elevated in cardiac muscles of chronic heart failure [7] and in infiltrating cells of atherosclerotic lesions such as smooth muscle cells and macrophages [8] . The mechanism for the elevation of levels of ET receptors in these diseases is at present unknown, but the dysregulation of GIPs for ET receptors might contribute to the elevated levels of ET receptors. As for GIPs of ET A R, only two proteins such as Tip 60 (histon acetyltransferase) and HDAC 7 (histon deacetylase) have been identified using yeast two-hybrid system and implicated in ET A R intracellular signaling [15] .
In this study, to identify the ET A R C-tail-interacting proteins, we have performed yeast two-hybrid screening of adult human heart cDNA library using C-tail of ET A R as a bait. Among ET A R-interacting proteins, we have identified Jun activation domain-binding protein 1 (Jab1). Jab1 was originally discovered as a protein interacting with c-Jun protein, which combined with Fos protein to form a gene regulatory protein complex, AP-1 [16] . In additon, Jab1 was shown to interact with p27
Kip1 [17] , p53 [18] and lutropin/choriogonadotropin receptor (LHR) precursor [19] and to accelerate the degradation of these proteins. Recent studies have shown that Jab1 overexpression induces ubiquitination of some of its interacting partners [20, 21] . Jab1 is reported to be a member of COP9 signalosome (CSN) which interacts with cullin-RING type E3 ubiquitin ligases, and regulates the activity of that enzyme [22, 23] .
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Here, we report that the amount of Jab1 bound to ETR regulates the degradation rate of ET A R and ET B R by modulating ubiquitination of these receptors, leading to changes in ET A R and ET B R levels.
Materials and methods

Antibodies
Mouse monoclonal anti-myc-tag antibody, rabbit polyclonal anti-phospho-p44/42 MAPK (p-ERK1/2)
antibody and rabbit polyclonal anti-p44/42 MAPK (ERK1/2) antibody were purchased from Cell
Signaling. Mouse monoclonal anti-Jab1 antibody, mouse monoclonal anti-GAPDH antibody and mouse monoclonal anti-ubiquitin antibody were purchased from Santa Cruz. Mouse monoclonal anti-FLAG antibody conjugated to horseradish peroxidase (HRP) was purchased from Sigma. Goat anti-mouse IgG or anti-rabbit IgG antibody conjugated to HRP was purchased from Jackson ImmunoResearch.
Plasmid construction
For yeast two-hybrid screening or GST pull-down assay, the C-terminal region of human ET A R (373-427 amino acids) was amplified by RT-PCR and subcloned into pGBKT7 vector containing the GAL4 DNA-binding domain (Clontech) or pGEX-5X-1 vector containing GST cDNA (GE Healthcare), respectively. For co-immunoprecipitation and Western blotting, PCR products of full-length human ET A R cDNA or Jab1 cDNA were subcloned into pMXrmv5-(G 4 S) 3 YFP1-myc retroviral vector (for 5 expression of ET A R-myc) or pcDNA3-FLAG vector (Invitrogen) (FLAG-Jab1), respectively. For confocal microscopic study, the PCR products were subcloned into pMXrmv5-(G 4 S) 3 YFP retroviral vector (ET A R-YFP) or pMXrmv5-(G 4 S) 3 CFP retroviral vector (Jab1-CFP), respectively.
Yeast two-hybrid screening
Yeast two-hybrid screening was performed using the MATCHMAKER two-hybrid system 3 (Clontech), according to the manufacturer's protocol.
Cell culture and transfection
All cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum at 37°C in a humidified atmosphere containing 5% CO 2 . For plasmid DNA transfection, the cells (80% confluent) were transiently transfected with pcDNA3-FLAG-Jab1 using Lipofectamine 2000 (Invitrogen), according to the manufacturer's protocol. For siRNA transfection, the cells (80% confluent) were transiently transfected with either scrambled (control) or Jab1 siRNA using DharmaFECT 1 (Dharmacon), according to the manufacturer's protocol. For construction of HEK293T cells stably expressing ET A R-myc (HEK293T/ET A R) and for confocal microscopy (Carl Zeiss LSM510 META), retroviral vector constructs were introduced into HEK293T cells.
GST pull-down assay
GST-ET A R C-tail fusion protein expressed in BL21-Gold bacteria was immobilized to glutathione-Sepharose beads (GE Healthcare), and incubated for 1 h at 4°C with whole cell lysates from HEK293T cells expressing FLAG-Jab1 protein. After washing (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% (v/v) Nonidet P-40), the proteins bound to GST-ET A R C-tail fusion protein were separated by SDS-PAGE, and immunoblotted with anti-FLAG antibody.
Western blotting
Cells were lysed by incubation on ice for 30 min with RIPA (radio-immunoprecipitation assay) buffer (50 
Co-immunoprecipitation
The cell lysates in RIPA buffer were incubated with protein G-Sepharose beads (GE Healthcare) for 30 min at 4°C for pre-cleaning. After centrifugation, 1-ml aliquots of the lysates containing 1 mg of protein were incubated with anti-myc-tag antibody (1 g) or anti-Jab1 antibody (1g) overnight at 4°C, followed by incubation with protein G-Sepharose beads (20 l) for 2 h at 4°C. After washing, the beads were incubated in Laemmli buffer at 25°C for 20 min to elute the bound proteins. After removal of the beads by centrifugation, the eluted proteins were separated by SDS-PAGE and immunoblotted with anti-myc-tag antibody, anti-Jab1 antibody, anti-FLAG antibody or anti-ubiquitin antibody.
Quantitation of cell surface ET A R
To measue cell surface level of ET A R-myc, biotinylation of cell surface proteins was performed in HEK293T/ET A R cells using membrane-impermeable biotin analog, sulfo-NHS-SS-biotin, according to the manufacturer's protocol (Pierce). After washing and lysis in RIPA buffer, biotinylated proteins purified by streptavidin-agarose beads (Sigma) were analyzed by Western blot with anti-myc-tag antibody.
Quantitation of ubiquitinated ET A R
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HEK293T/ET A R-myc cells were lysed with RIPA buffer containing 20 mM N-ethylmaleimide (NEM; Calbiochem) to prevent deubiquitination [24] . The cell lysates were immunoprecipitated with anti-myc-tag antibody, and immunocomplex was subjected to Western blot analysis with anti-ubiquitin antibody (1:1000).
Statistical analysis
The data were expressed as mean ± S.E.M. Statistical comparisons between two groups were done using Student's t-test. p < 0.05 (*) or p < 0.01 (**) was considered statistically significant.
Results and discussion
Identification of Jab1 as an ET A R-interacting protein
To identify the proteins that interact with ET A R C-tail, a yeast two-hybrid screening of a human heart cDNA library was performed using human ET A R C-tail as a bait. Among these ET A R C-tail-interacting clones, two independent clones containing the cDNA fragments encoding Jab1 were obtained.
FLAG-Jab1 was pulled-down with GST-ET A R C-tail fusion protein immobilized to the beads ( These results indicate ET A R C-tail interacts with Jab1 in vitro.
We next confirmed the interaction between ET A R and Jab1 in HEK293T cells, using co-immunoprecipitation experiments. Endogenous Jab1 was co-immunoprecipitated with ET A R-myc in HEK293T/ET A R-myc cells, but not in wild-type HEK293T cells (Fig. 1B, upper panel, lanes 1 and 2) .
Both FLAG-Jab1 and endogenous Jab1 were co-immunoprecipitated with ET A R-myc in HEK293T/ET A R-myc cells expressing FLAG-Jab1 (Fig. 1B, upper anti-Jab1 antibody, endogenous Jab1 and FLAG-Jab1 were found to be immunoprecipitated (Fig. 1C, lower panel, lanes 1 and 2). These results demonstrate that monomer, dimer and multimer of ET A R interact with Jab1.
Intracellular localization of ET A R and Jab1 was visualized with confocal microscopy in HEK293T cells expressing ET A R-YFP and Jab1-CFP. ET A R-YFP was predominantly localized at the plasma membrane (Fig. 1D, left panel) , whereas Jab1-CFP was diffusely distributed in the cytosol and nucleus (Fig. 1D, middle panel). The overlay image shows the merged color (yellow) on the periphery of the cells (Fig. 1D , right panel). Combined with the data by immunoprecipitation study, these results suggest that ET A R-myc is present in monomer, dimer and multimer mainly on the cell surface, where Jab1 interacts with each form of ET A R.
Effect of Jab1 overexpression or knockdown on ET A R levels
Following overexpression of FLAG-Jab1, the level of total ET A R which is the sum of monomer, dimer and multimer was significantly decreased in comparison with that in the cells transfected with an empty vector (Fig. 2, A and B ). The levels of ET A R dimer and multimer but not that of monomer were significantly decreased ( Supplementary Fig. S1 , A). In contrast, following Jab1 knockdown with its siRNA, the level of total ET A R was significantly increased in comparison with that in the cells transfected with scrambled siRNA (control siRNA) (Fig. 2, C and D) . The levels of ET A R dimer and multimer but not that of monomer were significantly increased ( Supplementary Fig. S1 , B). Following knockdown of endogenous Jab1, the levels of total and each form of ET A R on cell surface determined by biotinylation assay were significantly increased in comparison with those in HEK293T/ET A R-myc cells transfected with control siRNA (Supplementary Fig. S1 , C and D). Taken together, these results suggest that Jab1 negatively regulates whole cell and cell surface levels of ET A R.
Effect of Jab1 overexpression or knockdown on ET-1-induced ERK1/2 phosphorylation
In control cells, the level of p-ERK1/2 was negligible before ET-1 stimulation: it reached the maximal level 5 min after ET-1 stimulation and thereafter gradually decreased as previously reported [6, 25] .
Jab1 overexpression decreased ET-1-induced ERK1/2 phosphorylation ( Supplementary Fig. S2, A and B) , whereas Jab1 knockdown increased them ( Supplementary Fig. S2, C and D) . These results suggest that Jab1 regulates ET A R-mediated intracellular signaling by regulating ET A R levels.
Jab1 promotes degradation of ET A R
To elucidate the mechanism by which Jab1 regulates ET A R levels, we examined the effect of Jab1 on degradation rate of ET A R which was determined by the rate of disappearance for ET A R-myc after treatment with a protein synthesis inhibitor, cycloheximide (CHX, Calbiochem). In the absence of Jab1 overexpression, the level of total ET A R decreased with time up to 24 h after treatment with CHX, and at 24 h, it was about 46% of control level (Fig. 2E , left panel and Fig. 2F ). Following Jab1 overexpression, the rate of disappearance for total ET A R became significantly faster and at 24 h, it was 24% of control level (Fig. 2E , right panel and Fig. 2F ). Similar results were obtained for each form of ET A R (data not shown). ET A R was constitutively ubiquitinated, and the level of ubiquitination was enhanced by Jab1 overexpression (Fig. 2, G and H) . These results suggest that Jab1 promotes degradation of ET A R by enhancing its ubiquitination.
Long-term ET-1 stimulation promotes ET A R degradation and ET A R-Jab1 interaction
Because long-term agonist exposure was reported to promote degradation for many GPCRs (26), we assessed changes in ET A R levels, degradation rate and the amount of Jab1 bound to the receptor.
Long-term ET-1 stimulation decreased the level of ET A R in a time-dependent manner (Fig. 3A, lower panel), but it increased the amount of Jab1 bound to the receptor with a maximal level of 500% at 3h (Fig.   3A , upper panel and Fig. 3B ). Long-term ET-1 stimulation markedly increased the rate of ET A R degradation (Fig. 3, C and D) . These results suggest that an increase in degradation rate of ET A R after long-term ET-1 stimulation is mediated by an increase in the amount of Jab1 bound to ET A R.
Comparison of degradation rate, ubiquitination level and the amount of Jab1 bound to ET A R and ET B R
It is reported that in the absence or presence of ET-1 stimulation, ET A R is primarily targeted to recycling pathway, whereas ET B R is exclusively targeted to lysosomal pathway for degradation (27, 28).
To get insights into a mechanism for a faster degradation rate of ET B R, we compared the expression level, degradation rate, ubiquitination level and the amount of bound Jab1 of ET B R with those of ET A R. In the absence of ET-1 stimulation, the level of ET B R was lower than that of ET A R (Fig. 4B ) and the rate of ET B R degradation was faster than that of ET A R (Fig. 4 , A and C), as expected. In immunoprecipitation experiments, Jab1 was confirmed to interact with ET B R (Fig. 4D) . Notably, the amount of Jab1 bound to ET B R (Fig. 4 , D and E) and ubiquitination level of ET B R (Fig. 4 , F and G) were markedly higher than those for ET A R. These results suggest that the difference of degradation rate between ET A R and ET B R is due to the different amount of Jab1 bound to both receptors and subsequent ubiquitination level between ET A R and ET B R.
Concluding remarks
We identified Jab1 as a protein interacting with ET A R and ET B R and demonstrated that the amount of Jab1 bound to both receptors regulates degradation rate of ET A R and ET B R by modulating ubiquitination of these receptors, leading to changes in ET A R and ET B R levels. This conclusion is based on the following observations. First, in the absence of ET-1 stimulation, the amount of Jab1 bound to ET A R and ET B R was positively correlated with ubiquitination level and degradation rates of ET A R and ET B R, causing a change in both receptor levels opposite to that of the amount of Jab1. Second, ET-1 stimulation induced an increase in the amount of Jab1 bound to ET A R and degradation rate of ET A R.
Third, a faster degradation rate of ET B R in comparison with that of ET A R was associated with higher levels of bound Jab1 and ubiquitination for ET B R.
To elucidate the detailed molecular mechanisms for ubiquitination and degradation of ETR by Jab1, we must clarify the ubiquitination-related enzymes (E2 and E3) specific for ETR, ubiquitination sites of ETR, a role of ubiquitination in ETR trafficking, the relationship between ubiquitination and phosphorylation in the context of ETR trafficking. detected by Western blotting, and the data were represented as described in Fig. 2 (D) . *, p < 0.05 or **, p < 0.01; significantly different (n=3). 
